Total Funding
50
Total FundingSeries C raised
Growth Score in past quarter
pts
Heat Score 50 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1226732
Arakis Limited focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.
- Robin Bannister: Co-Founder
About the Company
Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or
known drug templates, as well as termed performance enhanced medicines.
